Maryanne Demasi, reports

Maryanne Demasi, reports

FDA stalls decision on petition to suspend mRNA injections, citing ‘other priorities’

The US regulator quietly delays action on a petition calling for the suspension of mRNA injections—despite evidence of regulatory failure, DNA contamination, and a surge in cancers among young people.

Maryanne Demasi, PhD's avatar
Maryanne Demasi, PhD
Jul 20, 2025
∙ Paid
174
15
43
Share

The U.S. Food and Drug Administration (FDA) has delayed its response to a formal petition demanding the suspension of the mRNA Covid-19 injections, citing “the existence of other FDA priorities.”

In a letter dated 17 July 2025, Dr Vinay Prasad—recently appointed Director of the FDA’s Center for Biologics Evaluation and Research (CBER)—acknowledged that the agency had “not yet reached resolution of the issues raised” in the petition.

Filed on 20 January 2025, the petition alleges that Pfizer’s Comirnaty and Moderna’s Spikevax were “unlawfully approved” in violation of federal regulatory requirements.

It calls for an immediate halt to the injections, independent testing of retained vials, and a full investigation into the approval process.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Maryanne Demasi
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture